iBio, Inc. (IBIO) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
600 MADISON AVENUE, SUITE 1601 NEW YORK, NY 10022-1737 |
| State of Incorp. | DE |
| Fiscal Year End | June 30 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2025 Q1 | 6/30/2025 Q4 | 3/31/2025 Q3 | 12/31/2024 Q2 | 9/30/2024 Q1 | 6/30/2024 Q4 | 3/31/2024 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 8,582 | 4,959 | 7,015 | 11,038 | 14,210 | 6,431 | |||
| Cash and cash equivalent | 8,582 | 4,959 | 7,015 | 11,038 | 14,210 | 5,302 | |||
| Short-term investments | |||||||||
| Other undisclosed cash, cash equivalents, and short-term investments | 1,129 | ||||||||
| Receivables | 713 | ||||||||
| Asset, held-for-sale, not part of disposal group | 14,957 | ||||||||
| Other undisclosed current assets | 1,139 | 1,101 | 1,270 | 667 | 749 | 14,751 | |||
| Total current assets: | 9,721 | 6,060 | 8,285 | 11,705 | 15,672 | 36,139 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 68 | 136 | 203 | 271 | 339 | 407 | |||
| Operating lease, right-of-use asset | 2,051 | 2,142 | 2,230 | 2,317 | 2,401 | 2,472 | |||
| Property, plant and equipment | 3,163 | 3,284 | 3,391 | 3,511 | 3,632 | 3,726 | |||
| Long-term investments and receivables | 1,098 | 1,129 | 1,115 | 1,101 | 1,081 | ||||
| Accounts and financing receivable, after allowance for credit loss | 1,098 | 1,129 | 1,115 | 1,101 | 1,081 | ||||
| Intangible assets, net (including goodwill) | 6,848 | 6,103 | 6,108 | 5,363 | 5,368 | 5,373 | |||
| Intangible assets, net (excluding goodwill) | 6,848 | 6,103 | 6,108 | 5,363 | 5,368 | 5,373 | |||
| Prepaid expense | 116 | ||||||||
| Restricted cash and investments | 210 | 223 | 223 | 223 | 215 | 215 | |||
| Other undisclosed noncurrent assets | 26 | 26 | 26 | 26 | 26 | 1,822 | |||
| Total noncurrent assets: | 13,464 | 13,043 | 13,412 | 12,812 | 13,062 | 14,015 | |||
| TOTAL ASSETS: | 23,185 | 19,103 | 21,697 | 24,517 | 28,734 | 50,154 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 3,533 | 2,802 | 2,449 | 1,932 | 2,386 | 5,226 | |||
| Accounts payable | 2,188 | 1,477 | 614 | 855 | 358 | 1,228 | |||
| Accrued liabilities | 1,345 | 1,325 | 1,835 | 1,077 | 2,028 | 3,998 | |||
| Deferred revenue | 1,200 | 600 | 600 | 400 | 200 | 175 | |||
| Debt | 883 | 1,519 | 1,198 | 688 | 818 | 12,947 | |||
| Disposal group, including discontinued operation | 1,933 | ||||||||
| Other undisclosed current liabilities | 490 | 476 | 462 | 449 | 436 | 1,145 | |||
| Total current liabilities: | 6,106 | 5,397 | 4,709 | 3,469 | 3,840 | 21,426 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 643 | 722 | 882 | 130 | |||||
| Long-term debt, excluding current maturities | 643 | 722 | 829 | ||||||
| Finance lease, liability | 53 | 130 | |||||||
| Liabilities, other than long-term debt | 2,199 | 2,325 | 2,450 | 2,572 | 2,688 | 2,801 | |||
| Operating lease, liability | 2,199 | 2,325 | 2,450 | 2,572 | 2,688 | 2,801 | |||
| Other undisclosed noncurrent liabilities | 934 | ||||||||
| Total noncurrent liabilities: | 2,199 | 2,325 | 3,093 | 3,294 | 3,570 | 3,865 | |||
| Total liabilities: | 8,305 | 7,722 | 7,802 | 6,763 | 7,410 | 25,291 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 14,880 | 11,381 | 13,895 | 17,754 | 21,324 | 24,863 | |||
| Common stock | 19 | 10 | 9 | 9 | 9 | 9 | |||
| Common stock, share subscribed but unissued, subscriptions receivable | (105) | (13) | |||||||
| Additional paid in capital | 347,085 | 338,432 | 336,086 | 335,581 | 335,162 | 330,923 | |||
| Accumulated other comprehensive loss | |||||||||
| Accumulated deficit | (332,224) | (327,061) | (322,200) | (317,836) | (313,847) | (306,069) | |||
| Other undisclosed equity, attributable to parent | 105 | 13 | |||||||
| Total equity: | 14,880 | 11,381 | 13,895 | 17,754 | 21,324 | 24,863 | |||
| TOTAL LIABILITIES AND EQUITY: | 23,185 | 19,103 | 21,697 | 24,517 | 28,734 | 50,154 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2025 Q1 | 6/30/2025 Q4 | 3/31/2025 Q3 | 12/31/2024 Q2 | 9/30/2024 Q1 | 6/30/2024 Q4 | 3/31/2024 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 200 | 200 | 175 | |||||
| Gross profit: | 200 | 200 | 175 | |||||
| Operating expenses | (5,398) | (4,879) | (4,619) | (4,106) | (3,584) | (3,626) | ||
| Operating loss: | (5,198) | (4,879) | (4,419) | (4,106) | (3,409) | (3,626) | ||
| Nonoperating income | 35 | 18 | 55 | 117 | 163 | 991 | ||
| Investment income, nonoperating | 79 | 72 | 112 | 174 | 223 | 43 | ||
| Interest and debt expense | (44) | (54) | (57) | (57) | 748 | (52) | ||
| Loss from continuing operations before income taxes: | (5,207) | (4,915) | (4,421) | (4,046) | (2,498) | (2,687) | ||
| Other undisclosed income (loss) from continuing operations | 44 | 54 | 57 | 57 | (636) | |||
| Loss from continuing operations: | (5,163) | (4,861) | (4,364) | (3,989) | (3,134) | (2,687) | ||
| Loss from discontinued operations | (4,532) | (537) | ||||||
| Other undisclosed net income (loss) | (112) | 52 | ||||||
| Net loss attributable to parent: | (5,163) | (4,861) | (4,364) | (3,989) | (7,778) | (3,172) | ||
| Other undisclosed net income available to common stockholders, basic | ||||||||
| Net loss available to common stockholders, diluted: | (5,163) | (4,861) | (4,364) | (3,989) | (7,778) | (3,172) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2025 Q1 | 6/30/2025 Q4 | 3/31/2025 Q3 | 12/31/2024 Q2 | 9/30/2024 Q1 | 6/30/2024 Q4 | 3/31/2024 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (5,163) | (4,861) | (4,364) | (3,989) | (7,778) | (3,172) | ||
| Other undisclosed comprehensive loss | ||||||||
| Comprehensive loss, net of tax, attributable to parent: | (5,163) | (4,861) | (4,364) | (3,989) | (7,778) | (3,172) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.